New Cell Manufacturing Research Facility will Change Approaches to Disease Therapies
By John Toon – The vision of making affordable, high-quality cell-based therapies available to hundreds of thousands of patients worldwide moved closer to reality June 6 with the dedication of a new cell manufacturing research facility at Georgia Tech aimed at changing the way we think about medical therapies.
The new Good Manufacturing Practice (GMP) like ISO 8 and ISO 7 compliant facility is part of the existing Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). The center was established in 2016 and made possible by a $15.75 million gift from philanthropist Bernie Marcus, with a $7.25 million investment from Georgia Tech and another $1 million from the Georgia Research Alliance.
MC3M is already helping researchers from Georgia Tech and partner organizations develop ways to provide therapeutic living cells of consistent quality in quantities large enough to meet the growing demands for the cutting-edge treatments. more>
Related>
- Sodium- and Potassium-based Batteries Hold Promise for Cheap Energy Storage, Josh Brown
- Georgia Tech Team Receives DARPA Grant to Apply Neuroscience to Machine Learning, Niccole Coleman
- Research Charts the Way to More Reliable Carbon-based Microelectronics, Josh Brown
- Making the Oxygen We Breathe, a Photosynthesis Mechanism Exposed, Ben Brumfield
- Aircraft Microbiome Much Like That of Homes and Offices, Study Finds, John Toon
- I Saw That. Brain Mechanisms Create Confidence About Things Seen, Ben Brumfield
- Spooky Quantum Particle Pairs Fly Like Weird Curveballs, Ben Brumfield
- In Child-Crippling Mucolipidosis IV, Drug Shows Hope in Lab Cultures, Ben Brumfield
- New Frontiers Beckon Math and Biology in Multimillion Dollar NSF-Simons Project, Ben Brumfield
- Shining a Light on Toxic Chemicals Curbs Industrial Use, Josh Brown
- Study Shows How Bacteria Behave Differently in Humans Compared to the Lab, John Toon
- Letting the Cat Out of the Bag: Why Researchers Disclose Results Ahead of Publication, Josh Brown
- Delving into the Perchlorate Diners of Pilot Valley, Utah, A. Maureen Rouhi
- Bacterial Conversations in Cystic Fibrosis, A. Maureen Rouhi
Economist – Both America’s armed forces and Silicon Valley are starting to focus on the brain. Facebook dreams of thought-to-text typing. Kernel, a startup, has $100m to spend on neurotechnology. Elon Musk has formed a firm called Neuralink; he thinks that, if humanity is to survive the advent of artificial intelligence, it needs an upgrade. Entrepreneurs envisage a world in which people can communicate telepathically, with each other and with machines, or acquire superhuman abilities, such as hearing at very high frequencies.
By Rick Merritt – After more than 20 years in development, 
By Bruce Watson & Dorothy Pomerantz – Online retailers have been tracking their customers and their web habits with cookies for years. No wonder their brick-and-mortar rivals are looking for new ways to play the big-data game.
By Wayne Hickey – When cable operators saw huge demands in linear video, Video-on-Demand (VoD) and high-speed data services, and faced with an aging analog infrastructure, they moved to a Converged Cable Access Platform (CCAP) to increase capacity and throughput. CCAP combines headend functions into a single architecture by combing Edge Quadrature Amplitude Modulation (EQAM) and Cable Modem Termination System (CMTS).
By Dave Lammers – It was back in 1985 that Ross Freeman invented the FPGA, gaining a fundamental patent (#4,870,302) that promised engineers the ability to use “open gates” that could be “programmed to add new functionality, adapt to changing standards or specifications, and make last-minute design changes.”
By Bruce Watson – When Mike Norton took over as managing director of real estate at JPMorgan Chase & Co. in 2015, he took on a weighty responsibility that included finding an efficient and sustainable way to oversee the branding, maintenance, upkeep and design of 6,000 branches and commercial properties around the world. It was a complex task that turned on a simple item: the light bulb.
By Ben Brumfield – Heart problems were much more common in the genes of our ancient ancestors than in ours today, 
By Alison Gillespie – Researchers at the National Institute of Standards and Technology (NIST) have produced and precisely measured a spectrum of X-rays using a new, state-of-the-art machine. The instrument they used to measure the X-rays took 20 years to develop, and will help scientists working at the agency make some of the world’s most accurate measurements of materials for use in everything from bridges to pharmaceuticals.
